Impact of Alzheimer's disease on the family caregiver's long-term quality of life: results from an ALSOVA follow-up study
TH Välimäki, JA Martikainen, K Hongisto… - Quality of Life …, 2016 - Springer
Purpose To examine caregivers’ health-related quality of life (HRQoL) and well-being
during the first 3 years after their family member’s Alzheimer’s disease (AD) diagnosis and …
during the first 3 years after their family member’s Alzheimer’s disease (AD) diagnosis and …
[HTML][HTML] Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI)
…, JPA Arokoski, RK Korhonen, JA Martikainen - PLoS …, 2019 - journals.plos.org
Background Knee osteoarthritis (OA) worsens health-related quality of life (HRQoL) but the
symptom pathway varies from person to person. We aimed to identify groups of people with …
symptom pathway varies from person to person. We aimed to identify groups of people with …
Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: cost-effectiveness and value of information analysis based on the 5-year follow-up …
…, JHO Turunen, C Asseburg, JA Martikainen - Acta …, 2011 - Taylor & Francis
Background. Trastuzumab is a standard treatment of HER2-positive early breast cancer in
many countries, and it is usually given as a one year adjuvant treatment. However, its cost-…
many countries, and it is usually given as a one year adjuvant treatment. However, its cost-…
[HTML][HTML] Health economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based …
JA Martikainen, EJO Soini, DE Laaksonen… - European journal of …, 2011 - nature.com
Results: During the next 20 years, a population-wide intervention directed at salt intake and
dietary fat quality could potentially lead to 8000–13 000 prevented CVD cases among the …
dietary fat quality could potentially lead to 8000–13 000 prevented CVD cases among the …
Economic evaluation of sunitinib malate in second-line treatment of metastatic renal cell carcinoma in Finland
T Purmonen, JA Martikainen, EJO Soini, V Kataja… - Clinical Therapeutics, 2008 - Elsevier
Background: Cytokine therapy is currently used as first-line treatment of metastatic renal cell
carcinoma (mRCC). Until recently, treatments with proven efficacy after the failure of first-line …
carcinoma (mRCC). Until recently, treatments with proven efficacy after the failure of first-line …
Register-based predictors of adherence among new statin users in Finland
EJ Aarnio, JA Martikainen, A Helin-Salmivaara… - Journal of clinical …, 2014 - Elsevier
Background Although register-based studies on statin adherence are increasing, for
administrative data, little is known about the explanatory power of the predictors that explain …
administrative data, little is known about the explanatory power of the predictors that explain …
Depressed spousal caregivers have psychological stress unrelated to the progression of Alzheimer disease: A 3-year follow-up report, Kuopio ALSOVA study
TH Välimäki, JA Martikainen… - Journal of geriatric …, 2015 - journals.sagepub.com
… The authors thank study nurse Helena Mäkelä and research assistants Markku Kalinen,
Janne Penttinen, and Lotta Salo for their valuable help, and the patients and their caregivers for …
Janne Penttinen, and Lotta Salo for their valuable help, and the patients and their caregivers for …
Longterm work productivity costs due to absenteeism and permanent work disability in patients with early rheumatoid arthritis: a nationwide register study of 7831 …
JA Martikainen, H Kautiainen, V Rantalaiho… - The Journal of …, 2016 - jrheum.org
Objective. To estimate the development and potential disproportional distribution of longterm
productivity costs (PC) and their determinants leading to work absenteeism and permanent …
productivity costs (PC) and their determinants leading to work absenteeism and permanent …
Population-based health-economic evaluation of the secondary prevention of coronary heart disease in Finland
EJO Soini, G Davies, JA Martikainen… - … medical research and …, 2010 - Taylor & Francis
Objective: To evaluate the cost-effectiveness of generic atorvastatin 20 mg (A20), branded
rosuvastatin 10 mg (R10), generic simvastatin 40 mg (S40) and the combination of generic …
rosuvastatin 10 mg (R10), generic simvastatin 40 mg (S40) and the combination of generic …
Economic evaluation of temozolomide in the treatment of recurrent glioblastoma multiforme
JA Martikainen, A Kivioja, T Hallinen, P Vihinen - Pharmacoeconomics, 2005 - Springer
Background: Temozolomide (TMZ) is an oral alkylating agent with demonstrated efficacy as
therapy for glioblastoma multiforme (GBM) and anaplastic astrocytoma. TMZ has widely …
therapy for glioblastoma multiforme (GBM) and anaplastic astrocytoma. TMZ has widely …